Privia Health Group, Inc.·4

Mar 10, 4:00 PM ET

Mountcastle David 4

4 · Privia Health Group, Inc. · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Privia Health (PRVA) CFO David Mountcastle Sells Shares

What Happened

  • David Mountcastle, Chief Financial Officer of Privia Health Group, sold a total of 11,006 shares in two open‑market transactions. On 2026-03-06 he sold 5,177 shares at $23.15 each for $119,848, and on 2026-03-09 he sold 5,829 shares at $22.84 each for $133,134, for combined proceeds of about $252,982. These were sales (not purchases).

Key Details

  • Transaction dates and prices:
    • 2026-03-06: 5,177 shares sold at $23.15 — $119,848
    • 2026-03-09: 5,829 shares sold at $22.84 — $133,134
  • Shares owned after transaction: Not disclosed in this Form 4 filing.
  • Footnote: The filing states these were nondiscretionary "sell to cover" transactions to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units.
  • Filing timeliness: Form filed 2026-03-10. The filing does not indicate a late filing flag.

Context

  • Sell‑to‑cover transactions are routine tax‑related sales tied to RSU vesting and generally do not signal management intent to reduce holdings for investment reasons. This was not a purchase or option exercise — it was a tax withholding sale of vested equity.

Insider Transaction Report

Form 4
Period: 2026-03-06
Mountcastle David
EVP & Chief Financial Officer
Transactions
  • Sale

    Common Stock, par value $0.01 per share

    [F1]
    2026-03-06$23.15/sh5,177$119,848167,732 total
  • Sale

    Common Stock, par value $0.01 per share

    [F1]
    2026-03-09$22.84/sh5,829$133,134161,903 total
Holdings
  • Common Stock, $0.01 par value per share

    (indirect: By Spouse)
    8,695
Footnotes (1)
  • [F1]The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Signature
/s/ Anita Beth Adams, as attorney-in-fact|2026-03-10

Documents

1 file
  • 4
    wk-form4_1773172822.xmlPrimary

    FORM 4